EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cordycepin Enhances the Therapeutic Efficacy of Doxorubicin in Treating Triple-Negative Breast Cancer

Haichen Huang, Xiaomin Li, Wenya Wu, Chengyi Liu, Yunhe Shao, Xiaoping Wu, Junsheng Fu iD

International Journal of Molecular Sciences · 27.06.2024 · 25 (13) · 7077

DOI: 10.3390/ijms25137077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.06.2024. Verfasst von Haichen Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China. Hauptthemen laut MEDLINE: Doxorubicin, Triple Negative Breast Neoplasms, Deoxyadenosines, Xenograft Model Antitumor Assays. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with high mortality and poor prognosis. Meanwhile, doxorubicin, a chemotherapeutic agent for triple-negative breast cancer, has poor sensitivity. The objective of this study was to examine the effect of cordycepin on doxorubicin sensitivity and efficacy in the TNBC xenograft model and explore the relevant molecular pathways. The combination of the drugs in nude mice carrying MDA-MB-231 xenografts significantly reduced the volume, size, and weight of xenografts and improved the tumor inhibition rate. The drug combination was significantly more effective than cordycepin or doxorubicin alone, reflecting the fact that cordycepin enhanced the anti-tumor effects of doxorubicin in MDA-MB-231 xenografts. At the same time, the monitoring of several biological parameters failed to detect any obvious side effects associated with this treatment. After predicting the importance of the TNF pathway in inhibiting tumor growth using network pharmacology methods, we verified the expression of TNF pathway targets via immunohistochemistry and quantitative PCR. Furthermore, a TNF-α inhibitor was able to abrogate the beneficial effects of cordycepin and doxorubicin treatment in MDA-MB-231 cells. This clearly indicates the role of TNF-α, or related molecules, in mediating the therapeutic benefits of the combined treatment in animals carrying TNBC xenografts. The observations reported here may present a new direction for the clinical treatment of TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinTriple Negative Breast NeoplasmsDeoxyadenosinesXenograft Model Antitumor AssaysMice, NudeAnimalsHumansFemaleMiceCell Line, TumorDrug SynergismTumor Necrosis Factor-alphaAntineoplastic Combined Chemotherapy ProtocolsCell ProliferationMice, Inbred BALB C

Stichwörter der Autor:innen

TNF signaling pathwaycordycepindoxorubicinnetwork pharmacologytriple-negative breast cancer

Substanzen

cordycepinDoxorubicinDeoxyadenosinesTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
  • Mycological Research Center, Fujian Agriculture and Forestry University, Fuzhou 350002, China.

ORCID-Profile: Junsheng Fu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, H., Li, X., Wu, W., Liu, C., Shao, Y., Wu, X., & Fu, J. (2024). Cordycepin Enhances the Therapeutic Efficacy of Doxorubicin in Treating Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 25(13), 7077. https://doi.org/10.3390/ijms25137077

Vancouver

Huang H, Li X, Wu W, Liu C, Shao Y, Wu X, et al. Cordycepin Enhances the Therapeutic Efficacy of Doxorubicin in Treating Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2024;25(13):7077. doi:10.3390/ijms25137077

BibTeX
@article{Huang2024,
  author = {Huang, Haichen and Li, Xiaomin and Wu, Wenya and Liu, Chengyi and Shao, Yunhe and Wu, Xiaoping and Fu, Junsheng},
  title = {Cordycepin Enhances the Therapeutic Efficacy of Doxorubicin in Treating Triple-Negative Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {13},
  pages = {7077},
  doi = {10.3390/ijms25137077}
}
Kostenlos starten →